Ads
related to: calculate breast cancer recurrence risk- Treatment Information
Read About This Treatment Option.
Learn How This Option May Help.
- Early Breast Cancer
Find Condition Information.
Understand eBC.
- Clinical Data
See The Data For This Option.
eBC Clinical Trial Information.
- Patient FAQ Answers
View Frequently Asked Questions.
Get Answers To Common Questions.
- Managing Day To Day
Info For Day To Day Support.
Find Support Organizations.
- Patient Support Program
Access Personalized Support.
View Financial Support Options.
- Treatment Information
Search results
Results From The WOW.Com Content Network
The Nottingham prognostic index (NPI) is used to determine prognosis following surgery for breast cancer. [1] [2] Its value is calculated using three pathological criteria: the size of the tumour; the number of involved lymph nodes; and the grade of the tumour. [1] It is calculated to select patients for adjuvant treatment.
The result is a lifetime risk and a five-year risk based on factors that have been tied to a higher risk of breast cancer. For comparison, it also gives an average risk for U.S. women of the same ...
MammaPrint is a prognostic and predictive diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other parts of the body. [1] It gives a binary result, high-risk or low-risk classification , and helps physicians determine whether or not a patient will benefit from chemotherapy .
Even light consumption of alcohol – one to three drinks per week – increases the risk of breast cancer. [3] Heavy drinkers are also more likely to die from breast cancer than non-drinkers and light drinkers. [3] [7] Also, the more alcohol a woman consumes, the more likely she is to be diagnosed with a recurrence after initial treatment. [7]
Progression-free survival (PFS) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse". [1] In oncology, PFS usually refers to situations in which a tumor is present, as demonstrated by laboratory testing, radiologic testing, or clinically. Similarly ...
Response evaluation criteria in solid tumors (RECIST) is a set of published rules that define when tumors in cancer patients improve ("respond"), stay the same ("stabilize"), or worsen ("progress") during treatment.
Ads
related to: calculate breast cancer recurrence risk